Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer

[News]

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines, according to preliminary late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.

More... (https://www.news-medical.net/news/20241118/Common-heart-failure-drug-reduces-risk-of-chemotherapy-induced-heart-damage-in-cancer-patients.aspx)